Resources
We've curated a compilation of internal and external resources and tools to help researchers, nephrologists, kidney patients, and the public navigate the challenges.
Human Research
Our robust clinical research infrastructure married with unique resources, including the electronic data warehouse, genomic data repository, access to CKD biosamples and a transplant kidney tissue biorepository, will ensure that preclinical discoveries are safely and ethically translated into the right patient population.
Nanotechnology
Leveraging the innovative research of the Evan Scott Lab at Northwestern University and the Eunji Chung Lab at USC, our initiative focuses on using advanced nanocarrier technology for therapeutics. This strategy aims to improve drug delivery to the kidney and other critical organs, enhancing therapeutic efficacy. Through this collaboration, we are committed to addressing challenges in kidney diseases and exploring new treatment possibilities in fields like immunotherapy, diabetes, and chronic kidney conditions.
Therapeutic Development
Northwestern University is the home of many state-of-the-art core services for therapeutics design, production, and validation, including the Chemistry of Life Processes Institute, the Center for Developmental Therapeutics and the Mathews Center for Cellular Therapy. We will leverage this broad expertise in transformative biologics, drug discovery and cellular therapeutics for development of experimental biological and small molecule therapeutics and cellular therapeutics targeting kidney disease-specific pathogenesis.
Commercialization
The Innovation and New Ventures Office offers robust support for innovation and commercialization and a track record in acquiring FDA approval for therapies developed at Northwestern University.
